Back to WELLS FARGO & COMPANY/MN WELLS FARGO & COMPANY/MN

KYTXKYTX
Showing 8 of 10 quarters

Position history for WELLS FARGO & COMPANY/MNWELLS FARGO & COMPANY/MN's holdings in KYVERNA THERAPEUTICS INC

WELLS FARGO & COMPANY/MN holds 373,009 shares of KYTX (KYVERNA THERAPEUTICS INC), worth $3.3M as of 2026-Q2. The position was increased (+226.1% shares). KYTX represents 0.0% of WELLS FARGO & COMPANY/MN's portfolio.

Current Value

$3.3M

Current Shares

373,009

Total Value Change

+$2.6M

Total Shares Change

+219,222

Quarter-by-Quarter History
QuarterActionSharesChangeValueWeightPriceConviction
2026-Q2
Latest
Increased
373,009
+226.1%
$3.3M0.0%$8.91
43
2026-Q1
Increased
114,399
+52.6%
$987,2630.0%$8.02
35
2025-Q4
Increased
74,949
+310.0%
$704,5210.0%$9.35
40
2025-Q3
Increased
18,280
+448.6%
$109,6800.0%$5.94
24
2025-Q2
Decreased
3,332
-80.0%
$10,2300.0%$3.28
0
2025-Q1
Decreased
16,678
-90.7%
$32,1880.0%$2.00
0
2024-Q4
Increased
179,012
+16.4%
$669,5050.0%$3.64
28
2024-Q3
Increased
153,787
+36.5%
$752,0180.0%$5.23
32

Other major holders of KYTX: RTW INVESTMENTS, LP, JENNISON ASSOCIATES LLC, BlackRock, Inc., PRICE T ROWE ASSOCIATES INC /MD/, BlackRock Finance, Inc.

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used